Aprea Therapeutics(APRE)
$0.44-0.00 (-0.90%)
APRE
Aprea Therapeutics financials statements
$0.44
At close:-0.00 (-0.90%)
Want to see APRE full AI Analyst Report?
Aprea Therapeutics (APRE) Income Statement
520 Followers
Aprea Therapeutics Income Statement
Last quarter (Q3 2026), Aprea Therapeutics's total revenue was $0.00. In Q3, Aprea Therapeutics's net income was $-4.81M. See Aprea Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 1.50M | $ 583.23K | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ -7.86M | $ 576.18K | $ -16.40M | $ -271.68K | |
| $ 13.23M | $ 6.46M | $ 16.05M | $ 96.99M | $ 37.17M | |
| Depreciation and Amortization | $ 21.71K | $ 22.32K | $ 7.05K | $ 186.44K | $ 271.68K |
| $ -12.58M | $ -12.94M | $ -14.28M | $ -37.19M | $ -36.86M | |
| $ -13.23M | $ -14.32M | $ -15.47M | $ -113.39M | $ -37.45M | |
| $ 634.27K | $ 1.36M | $ 1.19M | $ 730.20K | $ 319.05K | |
| $ -12.60M | $ -12.96M | $ -14.29M | $ -112.66M | $ -37.13M | |
| $ -12.60M | $ -12.96M | $ -14.29M | $ -112.66M | $ -36.54M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.93 | $ -2.35 | $ -3.95 | $ -1359.79 | $ -34.88 |
| Diluted EPS | $ -1.93 | $ -2.35 | $ -3.95 | $ -1359.79 | $ -34.88 |
| Weighted Average Shares Outstanding | 6.54M | 5.51M | 3.62M | 82.85K | 1.06M |
| Weighted Average Shares Outstanding (Diluted) | 6.54M | 5.51M | 3.62M | 82.85K | 1.06M |
Currency in USD
